TNeuroPharma

United States
Chico, California, United States, 87123

Company profile

TNeuroPharma company profile

TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Its technology helps to target the dysfunctional t-cells which helps in detecting Alzheimer's disease through the use of blood samples, enabling patients to detect and treat the disease at the early stage and to prevent any complications in the future. The company was founded in 2018 and is based in Albuquerque, New Mexico.

Business identity

Contact email
[email protected]
Phone number
575.644.1361
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2018-01-01, Year

Headquarters

Postal code
87123
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Last funding
Grant / $25,000 / 2022-03-31
Last equity funding
Seed
Investors
2
Lead investors
2
Articles
3

Founders and investors

Lead investors

Arrowhead Innovation FundNew Mexico Economic Development Department

Investors

Arrowhead Innovation FundNew Mexico Economic Development Department